Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|February 13, 2025
Hormones, Age, and Erectile Dysfunction: Should Routine Testing Be Part of the Initial Evaluation?Daniel Porav-Hodade, Raul Dumitru Gherasim, Irina Bianca Kosovski, et al.
Children (Basel, Switzerland)|March 28, 2026
Electrical and Functional Magnetic Stimulation in the Management of Children's Lower Urinary Tract Dysfunction-A Current Literature ReviewEdva Anna Frunda, András Kiss, Árpád Olivér Vida, et al.
Medicina (Kaunas, Lithuania)|August 28, 2025
Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic ImpactRaul-Dumitru Gherasim, Călin Chibelean, Daniel Porav-Hodade, et al.
Journal of Clinical Medicine|December 17, 2024
Prostate Dimensions and Their Impact on LUTS and Erectile Function: Is Length the Missing Link?Daniel Porav-Hodade, Mihai Dorin Vartolomei, Toader Septimiu Voidazan, et al.
Children (Basel, Switzerland)|October 29, 2025
Functional Magnetic Stimulation in the Management of Lower Urinary Tract Dysfunction in Children with Asperger Syndrome: A Case ReportEdva Anna Frunda, Orsolya Katalin Ilona Mártha, András Kiss, et al.
Cancers|November 27, 2024
Posterior Retroperitoneal Laparoscopic Adrenalectomy: An Anatomical Essay and Surgical UpdateBogdan Ovidiu Feciche, Vlad Barbos, Alexandru Big, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|August 22, 2025
Secondary Prostate Lymphoma Mimicking Prostate Cancer Successfully Managed by Transurethral Resection to Relieve Urinary RetentionLorand-Tibor Reman, Ovidiu Malau, Daniel Porav-Hodade, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Bladder Adenocarcinoma in a Constellation of Multiple Site Malignancies: An Unusual Case and Systematic ReviewDaniel Porav-Hodade, Raul Gherasim, Andrada Loghin, et al.
Cancers|April 14, 2026
Pathological Tumour Volume Percentage as a Quantitative Biomarker of Biological Aggressiveness in High-Risk Prostate CancerLorand Tibor Reman, Călin Chibelean, Daniel Porav-Hodade, et al.
Medicine|April 19, 2018
Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumorsDaniel Balan, Orsolya Martha, Calin Bogdan Chibelean, et al.
Pageof 3